A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 128
- Registration Number
- NCT00346957
Safety/Efficacy of Systane Free vs Refresh Liquigel
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 100
- Registration Number
- NCT00348517
Safety/Efficacy of Systane Free vs Refresh Tears
Not Applicable
Completed
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 100
- Registration Number
- NCT00348322
- Locations
- 🇺🇸
El Paso Facility, El Paso, Texas, United States
Safety of NGOIS Compared to BSS Plus in Pediatric Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 18
- Registration Number
- NCT00346528
- Locations
- 🇺🇸
Contact Alcon for Trial Locations, Fort Worth, Texas, United States
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 136
- Registration Number
- NCT00346866
- Locations
- 🇺🇸
Facility, Beachwood, Ohio, United States
Compliance With Once Daily Glaucoma Medication
- First Posted Date
- 2006-06-05
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 700
- Registration Number
- NCT00333463
- Locations
- 🇺🇸
Ft. Worth, Ft. Worth, Texas, United States
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 267
- Registration Number
- NCT00333255
- Locations
- 🇺🇸
Lehmann Eye Center, Nacogdoches, Texas, United States
Anecortave Acetate Risk-Reduction Trial (AART)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT00333216
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Nevanac 3-Month Safety Study With QID Dosing
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 149
- Registration Number
- NCT00332774
- Locations
- 🇺🇸
Contact Alcon for Trial Locations, Fort Worth, Texas, United States
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-06-02
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 369
- Registration Number
- NCT00333268
- Locations
- 🇺🇸
United States, Fort Worth, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath